Command Palette
Search for a command to run...
Epithelial and γδ T cell CD47 have complementary yet distinct roles in regulating γδ intraepithelial lymphocyte migration
Parthasarathy A, Fischer MA, Parkos CA, Edelblum KL.
CD47 has compartment-specific and opposing roles at the intestinal epithelium, with epithelial CD47 restricting gamma delta intraepithelial lymphocyte motility and lymphocyte-derived CD47 promoting it, while conditional deletion on either compartment leaves lymphocyte composition unchanged.
Moderate contradiction
2 prior failuresTwo documented clinical failures match this mechanism, or a single Phase 3 failure is on record.
Abstract excerpt
Intraepithelial lymphocytes expressing the γδ T cell receptor (γδ IEL) continuously survey the intestinal epithelium to promote mucosal host defense. Although γδ IELs migrate in and out of the lateral intercellular space (LIS) between adjacent enterocytes, the molecular mechanisms governing their migratory behavior are incompletely understood. Based on the known role of CD47, or integrin associated protein (IAP), in mediating neutrophil transepithelial migration, we investigated whether CD47 expression reflects a conserved mechanism regulating γδ IEL surveillance behavior. Here, we report that conditional CD47 deletion on intestinal epithelial cells or γδ T cells had no effect on IEL composition. Using intravital imaging, we identified complementary roles for CD47 on γδ IELs and epithelial cells, with epithelial CD47 restricting γδ IEL motility and γδ T-cell-derived CD47 promoting cell migration. Further investigation revealed that both CD47 and CD18 contribute to γδ IEL surveillance behavior, although CD47 regulates γδ IEL migration in a CD18-independent manner.
Matching Claidex post-mortems
2 of 2 indexed- Jul 27, 2026Evorpacept plus cetuximab and pembrolizumab stopped in MSS colorectal cancer after two fatal immune activation eventsEvorpacept (ALX148)SafetyMRS 33
- Jul 1, 2026Magrolimab in classic Hodgkin lymphoma: a responding trial closed when the CD47 program collapsedMagrolimab (Hu5F9-G4)SponsorMRS 27
This is an automated contradiction flag, not an editorial judgment on the preprint's quality. Flags identify where the preclinical literature and the clinical failure record diverge.

